CLINICAL EVALUATION OF BACAMPICILLIN IN RESPIRATORY TRACT INFECTIONS

DOI Web Site
  • ITOH KAZUHIKO
    First Department of Internal Medicine, Nagoya University School of Medicine
  • MORISE MASANORI
    First Department of Internal Medicine, Nagoya University School of Medicine
  • KOHNO OSAMU
    First Department of Internal Medicine, Nagoya University School of Medicine
  • SAKAI HIDEZO
    First Department of Internal Medicine, Nagoya University School of Medicine

Bibliographic Information

Other Title
  • 呼吸器感染症に対するBacampicillinの使用経験
  • コキュウキ カンセンショウ ニ タイスル Bacampicillin ノ シヨ

Search this article

Abstract

Bacampicillin was administered to patients of respiratory tract infections and favorable results were obtained. The following are the results of the clinical trial.<BR>1) Subjects were 14 out-patients and 5 in-patients (9 males and 10 females). The age ranged from 21 to 74 (41.2 on the average).<BR>2) The diseases are 8 cases of acute bronchitis, 3 cases of pneumonia, 3 cases of bronchiectasis, 2 cases of aggravation of chronic bronchitis. one case of interstitial pneumonia, one case of secondary infection to pulmonary tuberculosis, and one case of secondary infection to pulmonary carcinoma.<BR>3) Regarding the severity of the diseases, there were 8 mild, 8 moderate and 3 severe cases.<BR>4) The daily dosis were 750-1000 mg (ABPC titer), and the total amount of dosis ranged from 1.5g to 15g.<BR>5) There observed 11 effective cases, 5 fairly effective cases, 2 poor cases and one drop-out due to side effects.<BR>6) Two cases showed the gastrointestinal disturbances of nausea, vomiting and anorexia.

Journal

  • CHEMOTHERAPY

    CHEMOTHERAPY 27 (Supplement4), 119-122, 1979

    Japanese Society of Chemotherapy

Details 詳細情報について

Report a problem

Back to top